Sign in
4/A

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-21-019664

Chief Financial Officer gave up 666 shares (to pay taxes)

  • Chief Financial Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Estepan Ian Michael · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-28 Shares withheld for taxes : show line 1 in the form −319 $86.97 $27,743 13,723 D
2021-03-03 Grant or award : show line 2 in the form +15,000 28,723 D
2021-03-05 Shares withheld for taxes : show line 3 in the form −347 $84.65 $29,374 28,376 D
Loading xslF345X03/doc4a.xml…